Burden of Disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma

BACKGROUND: Isolated limb infusion (ILI) with melphalan is a minimally invasive, effective treatment for in transit melanoma. We hypothesized that burden of disease (BOD) would correlate to treatment response. METHODS: We retrospectively analyzed a prospectively collected database from two academic...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ann Surg Oncol
Hoofdauteurs: Muilenburg, Diego J., Beasley, Georgia M., Thompson, Zachary J., Lee, Ji-Hyun, Tyler, Douglas S., Zager, Jonathan S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505812/
https://ncbi.nlm.nih.gov/pubmed/25192683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4072-0
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items